Journal article
Levels of regulatory B cells do not predict serological responses to hepatitis B vaccine
M Bolther, KLD Andersen, M Tolstrup, K Visvanathan, I Woolley, N Skinner, R Millen, N Warner, L Østergaard, S Jensen-Fangel
Human Vaccines and Immunotherapeutics | TAYLOR & FRANCIS INC | Published : 2018
Abstract
This study investigated the immunomodulatory influence of IL10 producing B regulatory cells, Bregs (CD19+CD24hiCD38hi) to standard Twinrix® vaccination. We also investigated HBsAg specific T-cell mediated IFN-γ responses to Twinrix® which in theory could provide effective immunity despite low anti-HBs titer. A total of 309 hepatitis B negative health care students and workers completed a standard Twinrix® vaccination schedule (0, 1 and 6 months). Depending on the vaccination response the participants were divided in to non-, low- and high responders according to anti-HBs titer (<10, 1000 mIU/mL respectively) two months after completed vaccination schedule. Blood samples from baseline and aft..
View full abstract